HR+ breast cancer

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

HR+ breast cancer

Jul 17, 2024, 12:35 | Insight

Aleix Prat: Our review article about HR+ breast cancer in young women

Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…

Jul 2, 2024, 15:14 | Insight

Managing dose reduction without compromising outcomes of HR+ breast cancer

Stephen V Liu shared a post on X: “At the Upstate NY Cancer Symposium, Stephanie Graff…

Jun 18, 2024, 15:36 | Dialogues

ASCO24 Updates: Improving Sexual Health in Breast Cancer: LHRH Agonist Therapy

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Mar 21, 2024, 10:46 | Insight

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence - UCLA Health

Drug regimen significantly improves invasive disease-free survival for patients with stage 2 or 3 HR-positive,…

All: 4 Posts: 1 - 100